Australia approves Arrow and Apotex merger
The Australian Competition & Consumer Commission announced yesterday that it has approved the merger of generic drugs companies Arrow and Apotex.
Gilead HIV drug not entitled to SPC, says UK court
The English High Court has ruled that Gilead’s drug Truvada is not entitled to a supplementary protection certificate because it failed to meet the standards set out by Europe’s highest court earlier this year.
ERS extends CRISPR influence with two licensing deals
ERS Genomics and the Broad Institute of MIT and Harvard signed CRISPR licensing deals with Thermo Fisher Scientific on Tuesday, shortly before ERS expanded a separate agreement with Oxford Genetics.
CRISPR Therapeutics unites with ViaCyte to treat diabetes
Gene-editing company CRISPR Therapeutics has partnered with regenerative medicine-focused ViaCyte to focus on diabetes treatments.
Cancer Research UK invests £14m in biotherapeutics hub
Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million investment from charity Cancer Research UK.
Federal Circuit overturns PTAB decision, hands victory to DuPont
The US Court of Appeals for the Federal Circuit yesterday overturned a Patent Trial and Appeal Board decision that had said chemical company DuPont hadn’t proved that a patent was invalid.
Allergan to acquire medical aesthetics company for $195m
Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million.
Second scientist pleads guilty to stealing GSK trade secrets
A former GSK scientist has pleaded guilty to charges that he conspired to steal trade secrets to benefit a China-based company that he helped establish, according to the US Department of Justice.
MSF critical of EPO decision to uphold Gilead’s hepatitis C patent
The European Patent Office has upheld a patent covering Gilead’s hepatitis C medicine sofosbuvir, despite opposition from humanitarian organisation Médecins Sans Frontières.
J&J to acquire maker of 3D-printed spinal implants
Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.
